RedShift BioAnalytics, Inc. — Form D

RedShift BioAnalytics, Inc. of Boxborough, MA, a company, filed a Form D exempt-offering notice with the SEC on 2013-01-11. The offering totals $2.9M, of which $2.4M was reported sold. Industry: Other Technology.

Offering

Issuer

Officers, directors & promoters (19)

NameRoleLocation
Frank SmithDirectorMarlborough, MA
William CadoganDirectorBoxborough, MA
Bryson HollimonDirectorBoxborough, MA
Susan HolleranDirectorBoxborough, MA
Wouter MeulemanDirectorBoxborough, MA
Thomas O'LenicDirectorBoxborough, MA
Thomas O'LenicExecutive OfficerBoxborough, MA
Charles PurtellDirectorVienna, VA
Mark CafazzoDirectorBoxborough, MA
Amol ChaubalDirectorBoxborough, MA
Paul TardifDirectorWindham, NH
Julien BradleyDirectorBurlington, MA
Julien BradleyExecutive OfficerBurlington, MA
Don BossiDirectorMinneapolis, MN
Rob CarsonDirectorBurlington, MA
Charles MarshallDirectorBurlington, MA
Charles MarshallExecutive OfficerBurlington, MA
Eugene MaExecutive OfficerBurlington, MA
Bryson HollimanDirectorBurlington, MA

Other filings by this issuer (9)

FiledFormOfferingSold
2025-06-26D$7.1M$5.9M
2024-04-03D$7.0M$5.0M
2021-10-29D$20.0M$10.0M
2020-12-23D$6.4M$6.4M
2019-12-11D/A$18.3M$18.3M
2018-10-22D$10.0M$6.0M
2017-03-08D$10.8M$10.8M
2015-10-02D$2.0M$998K
2014-04-03D$1.8M$752K

More